Effectiveness of Online Exercise Training in Geriatric Population During COVID-19

January 10, 2025 updated by: Sıla YILMAZ, Medipol University

Investigation of the Effectiveness of Online Exercise Training in Geriatric Population Whose Daily Life Activity Level Decreased During COVID-19 Pandemic

The aim of this study is to investigate the effectiveness of online exercise training in geriatric population whose daily life activity level decreased during COVID-19 pandemic.

The main questions it aims to answer are:

  • Does online exercise training improve quality of life in the geriatric population whose daily life activity levels have decreased during the COVID-19 pandemic?
  • Does online exercise training improve sleep quality in the geriatric population whose daily life activity levels have decreased during the COVID-19 pandemic?
  • Does online exercise training affect depression status in the geriatric population whose daily life activity levels have decreased during the COVID-19 pandemic?
  • Does online exercise training reduce the risk of falls by improving balance and functional independence in geriatric population whose daily life activity levels have decreased during the COVID-19 pandemic?
  • Does online exercise training improve posture in geriatric population whose daily life activity levels have decreased during the COVID-19 pandemic?

Research data were collected by Sociodemographic Information Form, 36-Item Short Form Survey, The Pittsburgh Sleep Quality Index, Geriatric Depression Scale, Timed Up & Go Test, and New York Posture Rating Chart.

While no application was given to the control group, study group has received an online exercise training with a structured exercise program including range of motion, stretching, and, to train full body, low intensity aerobic exercises, once a week for 10 weeks, each lasting 60 minutes.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
20

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Istanbul, Turkey, 34000
        • Medipol University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteering to participate in the study
  • Being over 65 years old

Exclusion Criteria:

  • Having mental retardation at a level that prevents communication
  • Having an uncontrollable heart and hypertension problem
  • Being receiving medical treatment or rehabilitation for balance that may affect the balance level
  • Having osteoporosis at a level where exercise can be considered risky
  • Having a health problem where exercise is considered contraindicated

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Study group
Participants in the study group have received an online exercise training with a structured exercise program including range of motion, stretching, and, to train full body, low intensity aerobic exercises, once a week for 10 weeks, each lasting 60 minutes.
Other: Structured exercise program
The intervention applied in this research has an online exercise training conducting with a structured exercise program including different types of exercise which are range of motion, stretching and low intensity aerobic exercises. The exercise program continued with sessions each lasting 60 minutes, once a week for 10 weeks.
No Intervention: Control group
Participants in the control group were asked to maintain their daily physical activity routine.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
balance
Time Frame: This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
To determine fall risk and measure the progress of balance, sit to stand and walking, Timed-Up and Go Test was used. This is a simple screening test that is a sensitive and specific measure of probability for falls among older adults. An older adult who takes ≥12 seconds to complete the test is at risk for falling. The results of the Timed-Up and Go Test were obtained in seconds. This primary outcome was evaluated by interpreting these results.
This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
mobility
Time Frame: This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
To determine fall risk and measure the progress of balance, sit to stand and walking, Timed-Up and Go Test was used. This is a simple screening test that is a sensitive and specific measure of probability for falls among older adults. An older adult who takes ≥12 seconds to complete the test is at risk for falling. The results of the Timed-Up and Go Test were obtained in seconds. This primary outcome was evaluated by interpreting these results.
This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
sleep quality
Time Frame: This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
This outcome was evaluated by The Pittsburgh Sleep Quality Index. This is a self-report questionnaire that assesses sleep quality over a 1-month time interval. The measure consists of 19 individual items, creating 7 components that produce one global score. Each item is weighted on a 0-3 interval scale. The global score is then calculated by totaling the seven component scores, providing an overall score ranging from 0 to 21, where lower scores denote a healthier sleep quality.
This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
depression status
Time Frame: This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
This outcome was evaluated by Geriatric Depression Scale. According to the results of this questionnaire, a higher score is considered an indicator of more severe depression.
This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
posture
Time Frame: This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
This outcome was evaluated by New York Posture Rating Chart. This test includes a set of three figure drawings for each of different body alignment segments contributing to overall postural alignment. According to the results of this test, a higher score is considered an indicator of good posture.
This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
QoL
Time Frame: This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.
This outcome was evaluated by 36-Item Short Form Survey. This questionnaire evaluates 8 basic concepts related to health with 36 questions. Item scores for each quality of life area are coded and placed on a scale of 0-100 (0 is the worst, 100 is the best) using algorithms.
This outcome was evaluated twice, before starting the exercise program and after completing the exercise program.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Medipol University

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Istanbul Gedik University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Chair: Gönül ERTUNÇ GÜLÇELİK, Ph.D., Kocaeli University
  • Study Director: Sıla YILMAZ, M.Sc., Medipol University
  • Principal Investigator: Fatma Nur DÜLGER, Miss, Medipol University
  • Principal Investigator: Elvan EKİNCİ, Miss, Istanbul Gedik University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 1, 2022

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
May 31, 2023

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 31, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 8, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 8, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
August 12, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 10, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • E-714577430500104202121124-255

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Structured exercise program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings